Cholesterol Superlattice Modulates CA4P Release from Liposomes and CA4P Cytotoxicity on Mammary Cancer Cells
- 2 May 2012
- journal article
- Published by Elsevier BV in Biophysical Journal
- Vol. 102 (9), 2086-2094
- https://doi.org/10.1016/j.bpj.2012.03.063
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacyInternational Journal of Nanomedicine, 2011
- Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicinJournal of Peptide Science, 2010
- Cholesterol Modulates the Interaction of β-Amyloid Peptide with Lipid BilayersBiophysical Journal, 2009
- Chapter 12 Model Membrane Thermodynamics and Lateral Distribution of CholesterolMethods in Enzymology, 2009
- Assess the nature of cholesterol–lipid interactions through the chemical potential of cholesterol in phosphatidylcholine bilayersProceedings of the National Academy of Sciences of the United States of America, 2007
- Evidence that Nystatin Channels Form at the Boundaries, Not the Interiors of Lipid DomainsBiophysical Journal, 2006
- Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance ImagingJournal of Clinical Oncology, 2003
- Assessment of Pharmacodynamic Vascular Response in a Phase I Trial of Combretastatin A4 PhosphateJournal of Clinical Oncology, 2003
- Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic ResultsJournal of Clinical Oncology, 2003
- Modulation of Pig Kidney Na+/K+-ATPase Activity by Cholesterol: Role of HydrationBiochemistry, 2000